• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 369-383 of 901 results

1017 Exhibit: US Patent No 5,512,549

Document IPR2024-00009, No. 1017 Exhibit - US Patent No 5,512,549 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1005 Exhibit: Declaration of William J Jusko, PhD

Document IPR2024-00009, No. 1005 Exhibit - Declaration of William J Jusko, PhD (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1004 Exhibit: CV of John Bantle, MD

Document IPR2024-00009, No. 1004 Exhibit - CV of John Bantle, MD (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1006 Exhibit: CV of William J Jusko, PhD

Document IPR2024-00009, No. 1006 Exhibit - CV of William J Jusko, PhD (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1028 Exhibit: Holst, Glucagon Like Peptide 1, CURRENT OP IN PHARMACOLOGY...

Document IPR2024-00009, No. 1028 Exhibit - Holst, Glucagon Like Peptide 1, CURRENT OP IN PHARMACOLOGY 589 2004 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1015 Exhibit: WO 2006097537

Document IPR2024-00009, No. 1015 Exhibit - WO 2006097537 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1054 Exhibit: Landersdorfer, Mechanism Based,73 BRIT J CLINICAL PHARMACOL...

Document IPR2024-00009, No. 1054 Exhibit - Landersdorfer, Mechanism Based,73 BRIT J CLINICAL PHARMACOLOGY 391 2011 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

2016 Exhibit: EX2016 Transfer Order, In re Ozempic Semaglutide Patent Litigation...

Document IPR2024-00009, No. 2016 Exhibit - EX2016 Transfer Order, In re Ozempic Semaglutide Patent Litigation, No 22 MD 03038 CFC, Dkt 1 D Del Aug 5, 2022 (P.T.A.B. Jan. 26, 2024)

cite Cite Document
Analyze

2014 Exhibit: EX2014 Excerpt of Redacted Patent Owner’s Response, Mylan Phar...

Document IPR2024-00009, No. 2014 Exhibit - EX2014 Excerpt of Redacted Patent Owner’s Response, Mylan Pharms Inc v Novo Nordisk AS, IPR2023 00724, Pap30 Jan 17, 2023 (P.T.A.B. Jan. 26, 2024...

cite Cite Document
Analyze

2004 Exhibit: EX2004 Stipulation and Order Regarding Trial of the MPI Ozempic Li...

Document IPR2024-00009, No. 2004 Exhibit - EX2004 Stipulation and Order Regarding Trial of the MPI Ozempic Litigation, In re Ozempic Semaglutide Patent Litigation, No 22 MD 03038 CFC, Dkt 245 D D...

cite Cite Document
Analyze

2010 Exhibit: EX2010 Excerpt of Novo Nordisk’s Second Amended Disclosures to D...

Document IPR2024-00009, No. 2010 Exhibit - EX2010 Excerpt of Novo Nordisk’s Second Amended Disclosures to Dr Reddy’s Laboratories Ltd and Dr Reddy’s Laboratories, Inc, In re Ozempic Semaglutid...

cite Cite Document
Analyze

2007 Exhibit: EX2007 Excerpt of Transcript of Dec 13, 2023 Claim Construction He...

Document IPR2024-00009, No. 2007 Exhibit - EX2007 Excerpt of Transcript of Dec 13, 2023 Claim Construction Hearing, Novo Nordisk Inc v Mylan Pharmaceuticals Inc, No 23 101 CFC D Del Dec 13, 2023...

cite Cite Document
Analyze

1037 Exhibit: Nielsen, Pharmacology of Exenatide, 117 REGUL PEPTIDES 77 200...

Document IPR2024-00009, No. 1037 Exhibit - Nielsen, Pharmacology of Exenatide, 117 REGUL PEPTIDES 77 2004 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1090 Exhibit: Joint Claim Construction Brief, No 22 MD 3038 DDel May 1, 2023, ECF...

Document IPR2024-00009, No. 1090 Exhibit - Joint Claim Construction Brief, No 22 MD 3038 DDel May 1, 2023, ECF 119 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1098 Exhibit: District Court Order re Trial Date

Document IPR2024-00009, No. 1098 Exhibit - District Court Order re Trial Date (P.T.A.B. Mar. 29, 2024)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 25 26 27 28 29 ... >>